Epitopea USD $31 Million Pre-Series A Financing Announcement

“Scius Communications helped us amplify the news of our over subscribed pre-Series A financing announcement though high-impact coverage across global and regional media, effectively showcasing the transformative potential of our proprietary CryptoMap™ discovery platform.”

Alan C. Rigby

CEO of Epitopea

Objectives

Highlight Epitopea’s successful pre-Series A financing to position the company as a leading innovator in cancer immunotherapy.
Raise the visibility of Epitopea’s proprietary CryptoMap™ platform and its potential to deliver transformative RNA-based cancer immunotherapies.
Showcase the support of a diverse syndicate of new and existing investors across the transatlantic ecosystem.

Strategy

Collaborated with Epitopea to draft a press release emphasising the financing, investor support, and strategic vision.
Drafted an engaging LI post.
Conducted media outreach under embargo and targeted international trade publications and regional media.
This included trade outlets and regional media in the UK and Canada.

Results

The announcement was featured in major trade publications, including Endpoints News, BioWorld and Silicon Canals, including mentions in investment updates.
Secured coverage in key regional media outlets in the UK (Cambridge Independent) and Canada (Betakit).